';

Meta

Log in
Entries RSS
Comments RSS
WordPress.org

Recent Comments

Recent Posts

Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas April 12, 2018
All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation March 28, 2018

Unknown Feed

Search

Tag Cloud

Agricultural Technology AstraZeneca Bayer Bio-Rad Biopharma Bioproduction Biotech bluebird bio Boehringer Ingelheim Cancer Immunotherapy Celgene Cell Therapy Chemicals CRO/CMO Diagnostics Drug Development Evolution Global Press Releases Evolution Infographics GE Healthcare Genentech Gene Therapy Genomics & Proteomics GSK Illumina Informatics & Analytics Johnson & Johnson Juno Therapeutics KITE Pharma Life Sciences Lonza Medical Devices Merck Mergers Partnerships & Acquisitions Metagenomics MilliporeSigma Next Generation Sequencing Novartis Pfizer Regenerative Medicine Roche Sanofi Sartorius Stedim Sigma-Aldrich The Future of BioManufacturing Thermo Fisher Scientific

Text

Lorem ipsum dolor sit amet, consectetur adipiscing elit. In in lorem sit amet ligula feugiat vulputate vel vitae quam. Cras posuere imperdiet lorem, in aliquam urn

CategoriesTitle

Evolution Infographics
News & Analysis

ArchivesTitle

Cat tabs

: First
: Second
: Third

Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas

All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation

Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results
Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas

All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation
Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas

+44 141 248 2026info@evolution-bio.comNewsletter Sign-UpDownload Our BrochureEvolution Executive Search

Home
Clients & Core Services
News & Analysis
- The Future of BioManufacturing
IPO Tracker

Downstream Processing

The Future of Biomanufacturing: In Silico Modelling

The Future of Biomanufacturing: In Silico Modelling

More

Share

The Future of BioManufacturing: Downstream Processing

The Future of BioManufacturing: Downstream Processing

More

Share

The Future of BioManufacturing

More

Share

Search

THE FUTURE OF BIOMANUFACTURING

Browse By Category

Agricultural Technology Bioinformatics Biopharma Bioproduction Biotech Cancer Immunotherapy Cell Line Engineering Cell Therapy Chemicals CRO/CMO Diagnostics Downstream Processing Drug Development Gene Therapy Genomics & Proteomics Informatics & Analytics Life Sciences Medical Devices Mergers Partnerships & Acquisitions Metagenomics Modular Factories Molecular Pathology Next Generation Sequencing Regenerative Medicine The Future of BioManufacturing

Browse By Company

ACD Bio AstraZeneca Bayer Bio-Rad bluebird bio Boehringer Ingelheim Celgene Evolution Global Press Releases GE Healthcare Genentech GSK Illumina Johnson & Johnson Juno Therapeutics KITE Pharma Lonza Merck MilliporeSigma Novartis Pfizer Roche Sanofi Sartorius Stedim Sigma-Aldrich Thermo Fisher Scientific

STOCK TICKER

RECENT POSTS

Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas

All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation

Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results

More Efficient and Affordable Large-Scale Biomanufacturing: Have Novo Nordisk Foundation Made a Major Breakthrough?

Global Drug Development IPO Review: $6.4B Raised as Bullish Investors Back Biologics & Gene Therapies Despite Slowed Growth in 2017

DATA VISUALISATION

Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas

All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation

Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results

About Us

Evolution Bioscience is a global consultancy firm, specialising in market intelligence, strategy formulation, technology transfer and commercialisation services, covering the full range of Biotechnology sectors.

Get In Touch

+44 141 248 2026

info@evolution-bio.com

Recent Posts

Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas

Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas

All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation

All Eyes on Oxford Nanopore after further £100m funding raised at £1.5B Valuation

Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results

Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results

More Efficient and Affordable Large-Scale Biomanufacturing: Have Novo Nordisk Foundation Made a Major Breakthrough?

More Efficient and Affordable Large-Scale Biomanufacturing: Have Novo Nordisk Foundation Made a Major Breakthrough?

BROWSE NEWS BY INDUSTRY

Agricultural Technology Biopharma Bioproduction Biotech Cancer Immunotherapy Cell Therapy Chemicals CRO/CMO Diagnostics Drug Development Gene Therapy Genomics & Proteomics Informatics & Analytics Life Sciences Medical Devices Mergers Partnerships & Acquisitions Metagenomics Next Generation Sequencing Regenerative Medicine The Future of BioManufacturing

BROWSE NEWS BY COMPANY

Bayer Bio-Rad bluebird bio Celgene Evolution Global Press Releases Genentech GSK Illumina Juno Therapeutics KITE Pharma Lonza Merck MilliporeSigma Novartis Pfizer Roche Sanofi Sartorius Stedim Sigma-Aldrich Thermo Fisher Scientific

2016 © Evolution Bioscience / Darwin Hutton Partners

Search for: